AHOD2131: A randomized phase 3 response-adapted trial comparing standard therapy with immuno-oncology therapy for children and adults with newly diagnosed stage I and II classic Hodgkin lymphoma Meeting Abstract
| Authors: | Henderson, T. O.; Hu, B.; Keller, F.; Pei, Q.; Wu, Y.; Hoppe, B.; Milgrom, S.; Yao, S.; Khan, N.; Roth, L. G.; Mailhot, R.; Cho, S.; Parsons, S. K.; Kahn, J. M.; Duvall, A. S.; Hinds, P. S.; LaCasce, A.; Grover, N. S.; Allen, P. B.; Evens, A. M.; Schoder, H.; Castellino, S. M.; Kelly, K. M. |
| Abstract Title: | AHOD2131: A randomized phase 3 response-adapted trial comparing standard therapy with immuno-oncology therapy for children and adults with newly diagnosed stage I and II classic Hodgkin lymphoma |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 3084 |
| Language: | English |
| ACCESSION: | WOS:001159740302193 |
| DOI: | 10.1182/blood-2023-189652 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
